UBS Group’s GraniteShares YieldBOOST Biotech ETF BIOY Stock Holding History

UBS Group’s Portfolio BIOY Stock Details BIOY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23	Buy	+1	New	+$24	﹤0.01%	10264

Other funds holding BIOY

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group's BIOY Position: Q2 2026 in Review

UBS Group opened a new position in GraniteShares YieldBOOST Biotech ETF (BIOY) in Q2 2026: 1 share worth $23. The stake represents ﹤0.01% of the portfolio and ranks #10264 among its holdings.

2 funds tracked by Wall St. Rank hold BIOY as of Q2 2026.

UBS Group held 1 share of GraniteShares YieldBOOST Biotech ETF worth $23 as of Q2 2026.
GraniteShares YieldBOOST Biotech ETF was a new UBS Group position in Q2 2026.
GraniteShares YieldBOOST Biotech ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10264 holding.
2 funds tracked by Wall St. Rank held GraniteShares YieldBOOST Biotech ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.